, Tracking Stock Market Picks
Enter Symbol:
Xoma Ltd. (XOMA) [hlAlert]

Positive XOMA
down 97.40 %

Xoma Ltd. (XOMA) rated Positive with price target $5 by Susquehanna Financial

Posted on: Tuesday,  May 13, 2008  8:25 AM ET by Susquehanna Financial

Susquehanna Financial rated Positive Xoma Ltd. (NASDAQ: XOMA) on 05/13/2008, when the stock price was $31.95. Since
then, Xoma Ltd. has lost 97.40% as of 11/27/2015's recent price of $0.83.
If you would have followed this Susquehanna Financial's recommendation on XOMA, you would have lost 97.4% of your investment in 2754 days.

XOMA is a leader in the discovery, development and manufacture of therapeutic antibodies, with a therapeutic focus that includes cancer and immune diseases. XOMA has royalty interests in RAPTIVA, a monoclonal antibody product marketed worldwide to treat moderate-to-severe plaque psoriasis, and LUCENTIS, a monoclonal antibody product marketed worldwide to treat neovascular age-related macular degeneration. The company has built a premier antibody discovery and development platform that includes access to seven of the leading commercially available antibody phage display libraries and XOMA's proprietary Human Engineering and bacterial cell expression technologies. More than forty five companies have signed BCE licenses. XOMA's development collaborators include Lexicon Genetics, Inc., Novartis, and Schering-Plough Corporation. With a fully integrated product development infrastructure, XOMA's product development capabilities extend from preclinical sciences to product launch.

Since its inception in 1987, the Susquehanna International Group of Companies (SIG)* has grown from a trading firm on the Philadelphia Stock Exchange to one of the largest privately held financial institutions in the world. With more than 1,500 employees worldwide, SIG sits at the helm of the latest trends and developments in trading and market making, institutional sales, research, private equity, venture capital, and investment banking. SIG has offices across North America, Europe, Asia, and Australia. SIG distinguishes itself through its global market presence, capital commitment, and its grasp of trading dynamics. It excels at decision theory and implementing sophisticated pricing probability models.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
5/13/2008 8:25 AM Buy
31.95 75.00
as of 12/24/2008
1 Week down  -2.17 %
1 Month up  9.75 %
3 Months down  -31.81 %
1 YTD down  -27.41 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy